Tadej Avcin

[PReS @PReSociety_]

📢 PReS is now on social media!

Follow us and be the first to know about our initiatives and ongoing activities!

Let’s grow and strengthen our community together.

#PReS #PaediatricRheumatology #StayConnected

[Tadej Avcin @TadejAvcin]

Wonderful and stimulating mini symposium of the Central European pediatric rheumatology group was a great start of #CECR2024 congress. Ped rheum sessions are for the first time part of the main #CECR congress programme.🤝🇦🇹🇭🇷🇨🇿🇹🇯🇮🇹🇸🇰🇸🇮

[Eve smith @evemdsmith_eve]

📢Exciting news! Our paper on core & expanded datasets for cSLE research is out @ARD_BMJ! 🌍 Huge global collaboration supported by @carrainc & PReS/@PReSLupusWP. ⏲️Time to start collecting these data to collaborate & make a difference worldwide! 🤝 https://t.co/bbpuIPG5gC.

[Tadej Avcin @TadejAvcin]

Selfi photo of a wonderful group of the EU Interreg project #CONCERTO🤝🙏🇮🇹🇸🇮

[Interreg ITA SLO - Concerto @ITASLOConcerto]

20.09.24 - 11 a.m @ Faculty of Medicine, University of Ljubljana
🇮🇹 si terrà il meeting annuale del progetto CONCERTO.
🇸🇮 potekalo letno srečanje projekta CONCERTO.
🇬🇧 the annual meeting of the CONCERTO project will be held.
#InterregITASLO @InterregITASLO #Interregitasloconcerto

[Interreg ITA SLO - Concerto @ITASLOConcerto]

🇮🇹 Ecco il programma del meeting annuale che si terrà il 20.09: https://t.co/xtrJid63FI
🇸🇮 Tukaj je program letnega srečanja, ki bo potekalo 20.09: https://t.co/Wleq2zhO1a
🇬🇧Here is the programme for the annual meeting to be held on 20.09: https://t.co/LGTnKisI0c

#InterregITASLO

[Tadej Avcin @TadejAvcin]

Congratulations to all the winners of the best abstracts award at the #PReS2024 Young Investigators Meeting

[Tadej Avcin @TadejAvcin]

Welcome to the 25th anniversary of #PReS in Gothenburg!

[Tadej Avcin @TadejAvcin]

Very pleased to announce launching of PReS and Neutrolis partnership in developing target therapy in patients w/ DNASE1L3 def. Please register if interested https://t.co/j4YqDHgs82

[The Lancet Rheumatology @TheLancetRheum]

NEW SERIES on #pregnancy in rheumatic disease calls for a reconsideration of therapeutic decisions to optimise the safe and effective use of DMARDs, and proposes solutions to the challenges of studies in pregnancy
https://t.co/sNTtr1C6Oo #EULAR2024

[Annals of the Rheumatic Diseases @eular_ARD]

🌟 B-cell depletion in autoimmune diseases

🔷 Review
🔷Current therapeutic strategies to deplete B cells in order to ameliorate or potentially even cure autoimmune disease

🔗 https://t.co/2n1V31yymb

[Tadej Avcin @TadejAvcin]

Serum TNF-alpha levels do not correlate with JIA disease activity in patients treated with TNF inhibitors. These drugs extend TNF-alpha half-life and serum levels of TNF-alpha do not reflect inflammatory activity in the joints https://t.co/jF3fHkKuwR

[Tadej Avcin @TadejAvcin]

Thank you @AlexandreBelot for outstanding grand round and stimulating research discussions during the visiting professorship at the Univ. Children's Hospital Ljubljana 🇨🇵🇸🇮👏🤝

[Tadej Avcin @TadejAvcin]

Proud of my colleague Natasa Toplak showing safety data of prospective MMR/MMRV vaccine booster study in patients on biologics #Autoimmunity2024

[Tadej Avcin @TadejAvcin]

@MartaMartamosca @ern_reconnet Many thanks, Marta for your kind support of the pediatric rheumatology community🙏

[Tadej Avcin @TadejAvcin]

The CABC conference is also and exemplary model of collaboration between patients and physicians. Hearing and learning from touching testimonials from patients and parents🙏

[Tadej Avcin @TadejAvcin]

Amazing program and stimulating discussions at the UCAN Childhood arthritis & beyond conference in Toronto🇨🇦 🇳🇱 We are slowly getting closer to the biology based taxonomy of JIA. Very pleased to be invited and meeting old and new friends from SickKids!

[Tadej Avcin @TadejAvcin]

Please check the new HORIZON-MSCA PhD Position in Immunology at the UCH Ljubljana focusing on genomics and single-cell transcriptomics in JIA 👉https://t.co/C7JGXOd7oF
Deadline to apply 8th May 2024